Systematic review and meta-analysis of the prevalence of cognitive impairment no dementia in the first year post-stroke.
Eithne SextonAffraic McLoughlinDavid J WilliamsNiamh A MerrimanNora DonnellyDaniela RohdeAnne HickeyMaev-Ann WrenKathleen BennettPublished in: European stroke journal (2019)
A total of 7000 abstracts were screened, followed by 1028 full text articles. Twenty-three articles were included in the systematic review, and 21 in the meta-analysis. The pooled CIND prevalence was 38% [95% CI = 32-43%] (I2=92.5%, p < 0.01). Study quality emerged as one source of heterogeneity. The five studies with the highest quality scores had no heterogeneity (I2=0%, p = 0.99), with a similar pooled prevalence (39%, 95%CI = 35-42%). Other sources of heterogeneity were stroke type, inclusion of pre-stroke CI, and age at assessment time.Discussion and conclusion: Meta-analysis of available studies indicates that in the first year post-stroke, 4 in 10 patients display a level of cognitive impairment that does not meet the criteria for dementia.
Keyphrases
- cognitive impairment
- systematic review
- meta analyses
- risk factors
- single cell
- case control
- end stage renal disease
- atrial fibrillation
- mild cognitive impairment
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- quality improvement
- randomized controlled trial
- clinical trial
- smoking cessation
- blood brain barrier
- phase iii
- cerebral ischemia